C121H159F12N25O9 — CID 160538775
4-[[4-[[(1S,2S)-2-(azetidine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-4-[[4-[[(1S,2S)-2-(4-methylpiperazine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(morpholine-4-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(piperidine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide (PubChem CID 160538775) has the molecular formula C121H159F12N25O9 and a molecular weight of 2335.74 g/mol. Its IUPAC name is 4-[[4-[[(1S,2S)-2-(azetidine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-4-[[4-[[(1S,2S)-2-(4-methylpiperazine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(morpholine-4-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(piperidine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide.
| Compound Name | 4-[[4-[[(1S,2S)-2-(azetidine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-4-[[4-[[(1S,2S)-2-(4-methylpiperazine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(morpholine-4-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(piperidine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide |
|---|---|
| PubChem CID | 160538775 |
| Molecular Formula | C121H159F12N25O9 |
| Molecular Weight | 2335.74 g/mol |
| Exact Mass | 2334.26 |
| IUPAC Name | 4-[[4-[[(1S,2S)-2-(azetidine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-4-[[4-[[(1S,2S)-2-(4-methylpiperazine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-(1-methylpiperidin-4-yl)benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(morpholine-4-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide;N-methyl-N-(1-methylpiperidin-4-yl)-4-[[4-[[(1S,2S)-2-(piperidine-1-carbonyl)cyclopentyl]methyl]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide |
| SMILES | CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(C[C@@H]4CCC[C@@H]4C(=O)N4CCC4)n3)cc2)CC1.CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(C[C@@H]4CCC[C@@H]4C(=O)N4CCCCC4)n3)cc2)CC1.CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(C[C@@H]4CCC[C@@H]4C(=O)N4CCN(C)CC4)n3)cc2)CC1.CN1CCC(N(C)C(=O)c2ccc(Nc3ncc(C(F)(F)F)c(C[C@@H]4CCC[C@@H]4C(=O)N4CCOCC4)n3)cc2)CC1 |
| InChI | InChI=1S/C31H42F3N7O2.C31H41F3N6O2.C30H39F3N6O3.C29H37F3N6O2/c1-38-13-11-24(12-14-38)40(3)28(42)21-7-9-23(10-8-21)36-30-35-20-26(31(32,33)34)27(37-30)19-22-5-4-6-25(22)29(43)41-17-15-39(2)16-18-41;1-38-17-13-24(14-18-38)39(2)28(41)21-9-11-23(12-10-21)36-30-35-20-26(31(32,33)34)27(37-30)19-22-7-6-8-25(22)29(42)40-15-4-3-5-16-40;1-37-12-10-23(11-13-37)38(2)27(40)20-6-8-22(9-7-20)35-29-34-19-25(30(31,32)33)26(36-29)18-21-4-3-5-24(21)28(41)39-14-16-42-17-15-39;1-36-15-11-22(12-16-36)37(2)26(39)19-7-9-21(10-8-19)34-28-33-18-24(29(30,31)32)25(35-28)17-20-5-3-6-23(20)27(40)38-13-4-14-38/h7-10,20,22,24-25H,4-6,11-19H2,1-3H3,(H,35,36,37);9-12,20,22,24-25H,3-8,13-19H2,1-2H3,(H,35,36,37);6-9,19,21,23-24H,3-5,10-18H2,1-2H3,(H,34,35,36);7-10,18,20,22-23H,3-6,11-17H2,1-2H3,(H,33,34,35)/t2*22-,25-;21-,24-;20-,23-/m0000/s1 |
| InChIKey | QWMPJHXLVRTOSB-WRTYBBBNSA-N |
| XLogP | 18.33 |
| TPSA | 339.15 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 167 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2335.74 |
| LogP ≤ 5 | 18.33 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 26 |